HERAN Partners
VC Fund
Belgiek, Belgium
HERAN PARTNERS is a Belgian-based investment fund founded by Annie Vereecken together with Katleen Vandersmissen, Joris Mortelmans and Herman Verrelst within the sector of MedTech and Digital Health. With a clear focus on European HealthTech, the fund provides venture & growth capital accompanied by a strong network, expertise and mentorship tostartups and scale-ups with a strong technology platform and market potential.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 42%
Last updated:
For AI agents: llms.txt
Industries HERAN Partners invests in
Stages HERAN Partners invests in
Countries HERAN Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $2M–$8.1M
- Series A
- $12M–$23M
Investment Focus
Industry
- Software 4 (33%)
- Health Care 4 (33%)
- Artificial Intelligence 4 (33%)
- Machine Learning 3 (25%)
- Biotechnology 2 (17%)
Stage
- Series A 5 (42%)
- Seed 3 (25%)
- Funding Round 2 (17%)
- Series B 1 (8%)
- Venture - Series Unknown 1 (8%)
Country
- Belgium 3 (25%)
- United Kingdom 2 (17%)
- Spain 1 (8%)
- The Netherlands 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Katleen Vandersmissen
Managing Partner
|
Managing Partner | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Making surgeries more precise, safer and faster. Guiding the future of surgery using AI-powered hyperspectral imaging. | $23M / Series A / Apr 29, 2026 | ||
| Pharmacelera is a company that applies accurate Quantum-Mechanics (QM) algorithms, Machine Learning (ML) and High-Performance Computing (HPC) to mine an unexploited chemical space and propose molecular candidates that have higher chances to become a drug. The patented computational technology derives from more than 25 years of research at theUniversity of Barcelona and it has been validated in scientific peer-reviewed publications and benchmarking studies performed by our users and customers. | $7.1M / Venture - Series Unknown / Feb 18, 2026 | ||
| Aspect Analytics offers consultancy services, home-grown software, development of workflows, and customization of software. | $11.7M / Series A / Sep 09, 2025 | ||
| Nuclivision provides novel radiotracers and treatments for oncology that develop AI-driven solutions to help patients by improving the quality, safety, and accessibility of nuclear medicine. | $5.7M / Seed / Apr 24, 2025 | ||
| Broken String Biosciences is developing a platform of novel sequencing tools to assess genome stability and to unlock the next generation of innovative medicines, including cell and gene therapies. | $15M / Series A / Sep 18, 2023 | ||
| Thirona is a software solutions firm that offers services for software and image analysis services for the health care industry. | $5.4M / Series B / Sep 11, 2023 | ||
| Making surgeries more precise, safer and faster. Guiding the future of surgery using AI-powered hyperspectral imaging. | $8.1M / Seed / Jun 01, 2023 | ||
| LynxCare is an AI-powered Big Data platform. We enable hospitals to mine their legacy data, to improve clinical efficiency and higher the quality of care. | $21.1M / Series A / Jun 21, 2022 | ||
| Thirona is a software solutions firm that offers services for software and image analysis services for the health care industry. | Series A / Oct 27, 2021 | ||
| LynxCare is an AI-powered Big Data platform. We enable hospitals to mine their legacy data, to improve clinical efficiency and higher the quality of care. | $2M / Jan 29, 2020 | ||
| See all 12 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does HERAN Partners invest in?
HERAN Partners invests primarily in Software, Health Care and Artificial Intelligence startups, most often at Series A and Seed stage. Most of the 12 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is HERAN Partners's check size?
HERAN Partners typically joins rounds of $2M–$8.1M at Seed and $12M–$23M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds HERAN Partners participates in.
How do I contact HERAN Partners?
Public channels for HERAN Partners include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at HERAN Partners?
The team at HERAN Partners includes Katleen Vandersmissen (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
